Next Science : 2022 AGM

2022 AGM - NOTICE OF MEETING

Sydney, Australia, Friday, 22 April 2022: Next Science Limited (ASX:NXS) confirms that its 2022 Annual General Meeting (AGM) will be held at 10.00am (Sydney time) on Friday, 27 May 2022.

The AGM will be conducted as a hybrid meeting, with shareholders able to attend and participate in person at Dexus Place, Level 5, 1 Margaret Street, Sydney or virtually via an online platform at:https://meetings.linkgroup.com/NXS2022

The Notice of Meeting, Voting and Proxy Form, Online Meeting Guide and Question Form for the AGM have been sent to shareholders today and accompany this release.

The Notice of Meeting and Online Meeting Guide are also available on Next Science's website (together with Next Science's 2021 Annual Report which will be released separately today) at:https://investors.nextscience.com/investor-centre/?page=shareholder-meetings

The Notice of Meeting contains information on how shareholders may participate in the AGM including opportunities to ask questions. For shareholders who wish to attend the AGM virtually, the Online Meeting Guide contains more detailed information on how to use the online platform to view the AGM, vote and ask questions.

Approved and authorised for release by the Managing Director of Next Science Limited.

Further information:

Judith Mitchell	Michael Brown
Managing Director, Next Science Limited	Pegasus Advisory
Phone: [phone]	Phone: [phone]
Email:[e-mail]	Email:[e-mail]
About Next Science

Next Science is a medical technology company headquartered in Sydney, Australia, with a research and development centre in Florida, USA. Established in 2012, the Company's primary focus is on the development and commercialisation of its proprietary XbioTM technology to reduce the impact of biofilm based infections in human health. Xbio is a unique, non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Next Science owns 100% of the patent protected intellectual property relating to its Xbio technology. Website:www.nextscience.com.

Next Science Limited ACN 622 382 549

Suite 1902, Level 19, Tower A, The Zenith, 821 Pacific Highway, Chatswood NSW 2067www.nextscience.com

NOTICE OF

ANNUAL GENERAL

MEETING 2022

10.00am (Sydney time)

Friday, 27 May 2022

Dexus Place, Level 5, 1 Margaret Street, Sydney New South Wales and online

Next Science shareholders wishing to participate online should visit our website athttps://investors.nextscience.com/investor-centre/?page=shareholder-meetings for information on how to participate, including how to attend, vote and ask questions online.

Dear Shareholder,

On behalf of the Board of Directors of Next Science Limited (Next Science/Company), I am pleased to invite you to Next Science's 2022 Annual General Meeting (AGM).

The AGM will be held on Friday, 27 May 2022 commencing at 10.00am (Sydney time). Shareholders may choose to attend in person or virtually.

Virtual attendance. You may attend the AGM virtually by using the following online link:https://meetings.linkgroup.com/NXS2022.Online attendees will have the ability to ask questions and vote during the meeting. A guide on how to use the online facility is available on Next Science's website at:https://investors.nextscience.com/investor-centre/?page=shareholder-meetings

Physical attendance. The Annual General Meeting will be held physically at Level 5, 1 Margaret Street, Sydney. The venue is easily accessible from Wynyard train station and there are multiple parking stations located within walking distance.

Voting before the AGM. You may, and are encouraged to, enter your vote on the items of business ahead of the AGM by completing and returning the enclosed Voting and Proxy Form (or by voting online) no later than 10.00am (Sydney time) on Wednesday, 25 May 2022. The details on how to do this are specified in the Notice of Meeting and on the Voting and Proxy Form provided.

Questions and comments. I encourage you to submit questions and comments ahead of the AGM using the enclosed Question Form or online when you submit your votes. Instructions on how to do this are specified in this Notice of Meeting. We will endeavor to deal with any questions and comments received as follows:

• • Questions relating to specific items of business, including any questions for the auditor, will be dealt with when that item of business is being considered during the AGM;

• • Questions and comments regarding the management of Next Science will be dealt with following the CEO & Managing Director presentation; and

• • Questions that fall outside of the above areas and are appropriate will if possible, be addressed during the AGM or be forwarded to the appropriate staff member to address after the AGM.

Items of business. The formal items of business are set out on page 3. In addition, I will give an address as Chair and Judith Mitchell, Next Science's CEO & Managing Director, will present a business update. You will be able to listen to both the address and presentation via the online webcast. A copy of my address and the CEO & Managing Director presentation will also be released on the ASX prior to the commencement of the meeting and be available on Next Science's website.

If you have any questions regarding the AGM, please contact Next Science's share registrar, Link Market Services either by telephone on [phone] or by email [e-mail].

Thank you for your support of Next Science.

Yours sincerely,

Mark Compton AM Chair

2

ITEMS OF BUSINESS

1. Receipt of 2021 Annual Financial Report

To receive and consider the Annual Financial Report, the Directors' Report, and the Independent

• Auditor's Report of Next Science for the financial year ended 31 December 2021.

• 2. Remuneration report

  To consider and, if thought fit, pass the following as a non-binding ordinary resolution:

  "That the Company's Remuneration Report for the period 1 January 2021 to 31 December

  2021, as included in the Directors' Report, is adopted."

  Note: The vote on this item is advisory only and does not bind the Directors or Next Science.

  Board voting recommendation: The Directors abstain from making a recommendation in the interests of good corporate governance.

• 3. Director re-election

  To consider and, if thought fit, pass the following as an ordinary resolution:

  "That Bruce Hancox who retires pursuant to Rule 20.6(a) of the Company's Constitution, and

  being eligible, is re-elected as a director of the Company."

  Board voting recommendation: FOR

• 4. Approval of prior issue of shares

  To consider and, if thought fit, pass the following as an ordinary resolution:

  "That the issue of 6,666,667 fully paid ordinary shares at an issue price of $0.90 per share, on

  the terms and conditions set out in the Explanatory Notes which form part of this Notice of

  Meeting, is approved under and for the purposes of ASX Listing Rule 7.4 and all other

  purposes."

  Board voting recommendation: FOR

• 5. Approval to issue shares to Walker Group Holdings Pty Limited

  To consider and, if thought fit, pass the following as an ordinary resolution:

"That the issue of up to 4,444,445 fully paid ordinary shares to Walker Group Holdings Pty

Limited at an issue price of $0.90 per share, on the terms and conditions set out in the

Explanatory Notes which form part of this Notice of Meeting, is approved under and for the

purposes of ASX Listing Rule 10.11 and for all other purposes."

Board voting recommendation: FOR

The Explanatory Notes accompanying this Notice of Meeting provide additional information regarding the above items of business and form part of this Notice of Meeting.

By Order of the Board

Gillian Nairn Company Secretary 22 April 2022

IMPORTANT INFORMATION - PARTICIPATION AND VOTING

Determining if you are eligibile to vote and participate at the AGM

Voting Options	Details	Steps
Online prior to the AGM	You may vote your shares online prior to the AGM.	Go to:www.linkmarketservices.com.au To be effective, your votes must be received by Next Science no later than 10.00am (Sydney time) on Wednesday, 25 May 2022.
By post of fax prior to the AGM	Direct Vote Shareholders may complete Section A of the enclosed Voting and Proxy Form and deliver it to Next Science prior to the AGM. Shareholders should complete their voting directions by selecting 'FOR' or 'AGAINST' or 'ABSTAIN' for each resolution on the Voting and Proxy Form. Appoint a Proxy or Nominee Alternatively, Shareholders may appoint a proxy or proxies to vote and act on your behalf at the AGM. A proxy need not be a Shareholder and can be an individual or a body corporate.	Completed Voting and Proxy Forms may be posted to: Next Science Limited C/- Link Market Services Limited Locked Bag A14 Sydney South NSW 1235 Australia Alternatively, completed Voting and Proxy Forms may be faxed to: [phone] To be effective, your completed Voting and Proxy Form must be received by Next Science no later than 10.00am (Sydney time) on Wednesday, 25 May 2022.

Investor	Eligibility
Shareholder	In accordance with regulation 7.11.37 of the Corporations Regulations 2001 (Cth), registered holders of shares of Next Science as at 7.00pm (Sydney time) on Wednesday, 25 May 2022 will be entitled to participate in and vote at the AGM.
Joint holder	If more than one joint holder of shares participates in the AGM (whether personally, by proxy or by attorney or by representative) and tenders a vote, only the vote of the joint holder whose name appears first on the register will be counted.
Option holders	Not eligible to vote.

How you can vote

If you are entitled to participate in and vote at the AGM, you can vote your shares in one of the following ways.

Next Science reserves the right to declare a Voting and Proxy Form invalid if it is not received in a manner indicated below.

Shareholders are encouraged to call Next Science's share registry, Link Market Services (Link), if you have any questions regarding submitting your votes, by phoning 1800 990 363 (within Australia) or [phone] (Overseas).

4